Navigation Links
Carl A. Miller, PhD, Joins iDiverse's Business and Scientific Advisory Board
Date:1/11/2011

DEL MAR, Calif., Jan. 12, 2011 /PRNewswire/ -- iDiverse today announced that Dr. Carl A. Miller has joined the company's Business and Scientific Advisory Board.

"We are extremely pleased to have Dr. Miller join our team at this time," said John Burr, president and CEO of iDiverse. "Dr. Miller has over forty years of extensive, hands on experience in the commercialization of novel bio-based technologies that have greatly improved the economics of production of biofuels and biomaterials. He has been directly involved in solving some of the very difficult problems associated with the pretreatment and fermentation of biomass materials to biofuels and chemicals. We believe our technology can play a significant role here and I am looking forward to Dr. Miller's help and support."

"I believe that iDiverse's technology will play an immediate role in overcoming many of the generally accepted limitations in the production of biofuels from a wide variety of fermentation substrates. The iDiverse technologies represent breakthroughs in the conventional paradigm of biofuel production from any feedstock but its greatest impact will be realized in the biomass-to-biofuels sector," said Dr. Miller.

Dr. Miller has an expansive background ranging from the development of cost-effective biofuel production process designs to the commercialization of novel industrial enzymes. He has held positions at Novozymes, Gist-brocades (now DSM), Diversa (now Verenium), Innovase and Syngenta, and is currently the president of Enventek, a biotechnology consulting company. Dr. Miller earned his PhD in bio-organic chemistry from Clemson University and did post-doctoral work on enzyme mechanism at Syracuse University.

About iDiverse

iDiverse, Inc. is a privately-held biotechnology company dedicated to developing and commercializing genetically enhanced cell lines for use in the bioproduction of fuel ethanol, industrial enzymes, and pharmaceuticals. It also provides genetic technology for creating plants that are resistant to a wide range of biological and environmental stresses.


'/>"/>
SOURCE iDiverse, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Paul Pospisil Joins Korn/Ferry as Senior Client Partner in Biotechnology and Life Sciences Practice
2. Jack Davis, Diagnostics Industry Executive, Joins the HistoRx Board of Directors
3. Dr. Russell L. Chapman Joins Aquatic Energy as the Chairman of its Science Advisory Board
4. Dr. Michael Hanley Joins Celtaxsys as CEO
5. Edwin Rivera-Martinez, Former Chief of the FDA’s International Compliance Branch, Joins PAREXEL Consulting Strategic Compliance Team
6. Distinguished Scientist H. Mario Geysen Joins SRI International to Lead Combinatorial Sciences and Metabolic Diseases Research Programs
7. Dr. Eric Johnson Joins Transgenomic as Medical Director for Laboratory Services
8. Todd Park, Chief Technology Officer of U.S. Department of Health and Human Services, Joins Opening Keynote Line-Up at 2010 mHealth Summit
9. Heiner Dreismann, Ph.D., Former President of Roche Molecular Systems, Joins the HistoRx Board of Directors
10. Excerpta Medica Joins Adelphi Worldwide
11. Philadelphia Eagles Offensive Lineman Todd Herremans Joins SPO Medical to Endorse New SPO Wellness(TM) Product Line
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... N.J. , Feb. 4, 2016  CytoSorbents ... immunotherapy leader commercializing its flagship CytoSorb® blood filter ... surgery patients around the world, announced that CEO ... present at the Source Capital Group,s 2016 Disruptive ... update on the company.  Conference ...
(Date:2/4/2016)... N.J. , Feb. 4, 2016 ContraVir ... focused on the development and commercialization of targeted antiviral ... CEO & Investor Conference 2016, to be held February ... Source Capital Group,s 2016 Disruptive Growth & Healthcare Conference, ... on February 10-11, 2016. James Sapirstein , ...
(Date:2/4/2016)... , ... February 04, 2016 , ... ... and leading supplier of Semantic Graph Database technology has been recognized As “ ... ” by Corporate America Magazine. , “At Corporate America, it’s our priority to ...
(Date:2/3/2016)... SAN DIEGO , Feb. 3, 2016 /PRNewswire/ ... medicine company with the first pluripotent stem cell-derived ... 1 diabetes in clinical-stage development, today announced that ... Janssen Pharmaceutical Companies of Johnson & Johnson, have ... BetaLogics group into ViaCyte.  The agreement provides ViaCyte ...
Breaking Biology Technology:
(Date:1/27/2016)... , Jan. 27, 2016  Rite Track, Inc. ... in West Chester, Ohio announced ... winning service staff, based in Austin, Texas ... and ability to provide modifications, installations and technical support ... , CEO of PLUS, commented, "PLUS has provided world ...
(Date:1/21/2016)... 21, 2016 --> ... market research report "Emotion Detection and Recognition Market by Technology ... (Facial Expression, Voice Recognition and Others), Services, Application ... to 2020", published by MarketsandMarkets, the global Emotion ... USD 22.65 Billion by 2020, at a CAGR ...
(Date:1/15/2016)... , Jan. 15, 2016 Recent publicized ... small to find new ways to ensure data security ... iOS and Android that ties ... biometrics, transforming it into a hardware authorization token. Customer ... swipe their fingerprint on their KodeKey enabled device to ...
Breaking Biology News(10 mins):